Put Options

7 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 14, 2024

SELL
$114.22 - $140.1 $12.1 Million - $14.9 Million
-106,000 Reduced 34.64%
200,000 $27.7 Million
Q4 2023

Feb 13, 2024

SELL
$75.49 - $124.16 $20.8 Million - $34.2 Million
-275,100 Reduced 47.34%
306,000 $38 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $1.55 Million - $2.48 Million
18,000 Added 3.2%
581,100 $54.2 Million
Q2 2023

Aug 10, 2023

BUY
$112.47 - $130.98 $15.5 Million - $18 Million
137,500 Added 32.31%
563,100 $72.4 Million
Q1 2023

May 11, 2023

BUY
$104.0 - $122.92 $44.3 Million - $52.3 Million
425,600 New
425,600 $49.4 Million
Q2 2019

Aug 13, 2019

BUY
$27.84 - $38.92 $97,440 - $136,220
3,500 Added 7.0%
53,500 $8.02 Million
Q1 2019

May 13, 2019

BUY
$28.07 - $38.18 $1.4 Million - $1.91 Million
50,000 New
50,000 $5.96 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $27.2B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Ws Management Lllp Portfolio

Follow Ws Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Ws Management Lllp with notifications on news.